Status: current, Primitive. Date: 31-Jul 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3897070019 | Trastuzumab deruxtecan | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3897071015 | Trastuzumab deruxtecan (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Trastuzumab deruxtecan | Is a | Human epidermal growth factor receptor 2 inhibitor | true | Inferred relationship | Some | ||
| Trastuzumab deruxtecan | Has disposition | Immunomodulator | true | Inferred relationship | Some | ||
| Trastuzumab deruxtecan | Is a | Enzyme inhibitor protein | true | Inferred relationship | Some | ||
| Trastuzumab deruxtecan | Has disposition | Human epidermal growth factor receptor 2 inhibitor | true | Inferred relationship | Some | ||
| Trastuzumab deruxtecan | Is a | Murine-human monoclonal IgG antibody | false | Inferred relationship | Some | ||
| Trastuzumab deruxtecan | Is modification of | Trastuzumab | false | Inferred relationship | Some | ||
| Trastuzumab deruxtecan | Is a | Antineoplastic agent | false | Inferred relationship | Some | ||
| Trastuzumab deruxtecan | Is a | Immunosuppressant | true | Inferred relationship | Some | ||
| Trastuzumab deruxtecan | Is a | Monoclonal antibody | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Trastuzumab deruxtecan-containing product | Has active ingredient | True | Trastuzumab deruxtecan | Inferred relationship | Some | 1 |
| Trastuzumab deruxtecan only product | Has active ingredient | True | Trastuzumab deruxtecan | Inferred relationship | Some | 1 |
| Trastuzumab deruxtecan-containing product in parenteral dose form | Has active ingredient | True | Trastuzumab deruxtecan | Inferred relationship | Some | 1 |
| Trastuzumab deruxtecan only product in parenteral dose form | Has active ingredient | True | Trastuzumab deruxtecan | Inferred relationship | Some | 1 |
| Trastuzumab deruxtecan 100 mg powder for solution for infusion vial | Has precise active ingredient | True | Trastuzumab deruxtecan | Inferred relationship | Some | 1 |
| Trastuzumab deruxtecan 100 mg powder for solution for infusion vial | Has BoSS | True | Trastuzumab deruxtecan | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
Description inactivation indicator reference set
FHIR